This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Christensen, C. W. Articles by Port, S. C. Search for Related Content PubMed PubMed Citation Articles by Christensen, C. W. Articles by Port, S. C.

Circulation, Vol 83, 294-303, Copyright © 1991 by American Heart Association

ARTICLES

Coronary vasodilator reserve. Comparison of the effects of papaverine and adenosine on coronary flow, ventricular function, and myocardial metabolism

CW Christensen, LB Rosen, RA Gal, M Haseeb, TA Lassar and SC Port
Department of Medicine, University of Wisconsin Medical School, Sinai Samaritan Medical Center, Milwaukee 53233.

To evaluate coronary flow reserve during cardiac catheterization, intracoronary adenosine and papaverine have been used in the clinical setting. Although papaverine maximizes coronary blood flow, it induces several toxic side effects that reduce its desirability as a coronary dilator. This investigation was designed to compare the subselective intracoronary administration of papaverine with that of adenosine in an animal model. In dogs (n = 34), we studied the effects of each agent on hemodynamics, regional myocardial blood flow, contractility (sonomicrometric and echocardiographic), metabolism (coronary arterial and venous lactate and tissue high-energy phosphates), and electrocardiographic (ST and QT intervals) parameters. Barbiturate and morphine anesthesia/analgesia was induced, and a left thoracotomy was performed. An arterial shunt was created from the left carotid artery to the left anterior descending coronary artery. Two separate groups were studied: group 1 (n = 16) for regional myocardial blood flow and mechanical function and group 2 (n = 18) for biochemical measurements. Adenosine (67 +/- 2 micrograms/min) or papaverine (6 +/- 1 mg/min) was infused into the coronary shunt at a rate of 0.5 + 0.1 ml/min for a maximum duration of 3.5 minutes. Regional myocardial blood flows were determined at control (predrug) and maximal coronary flow using radiolabeled microspheres. All hemodynamic, wall motion, biochemical, and electrocardiographic parameters were also measured at these times. Both drugs produced comparable increases in total and regional coronary blood flows (adenosine, 1.21 +/- 0.15 to 4.83 +/- 0.36 ml/min/g; papaverine, 1.21 +/- 0.05 to 4.89 +/- 0.28 ml/min/g) upon infusion into the left anterior descending coronary artery. Papaverine produced significant (p less than 0.05) changes in subendocardial ST segment electrocardiogram (-2.5 mm), QT prolongation (8 +/- 2%), myocardial creatine phosphate (47% decrease), and coronary sinus serum lactate (277% increase) compared with control. In addition, intracoronary papaverine induced an abnormal contractile pattern. No significant changes in any of these parameters (i.e., ST segment, QT prolongation, myocardial creatine phosphate level, or lactate level) were observed with intracoronary adenosine infusions. We conclude that intracoronary adenosine is comparable to papaverine for maximizing coronary blood flow without the deleterious properties observed with intracoronary papaverine.

This article has been cited by other articles:

				M. Billinger, C. Seiler, M. Fleisch, F. R. Eberli, B. Meier, and O. M. Hess Do beta-adrenergic blocking agents increase coronary flow reserve? J. Am. Coll. Cardiol., December 1, 2001; 38(7): 1866 - 1871. [Abstract] [Full Text] [PDF]

				A. L'Abbate, G. Sambuceti, S. Haunso, and J. Schneider-Eicke Methods for evaluating coronary microvasculature in humans Eur. Heart J., September 2, 1999; 20(18): 1300 - 1313. [PDF]

				U. Schwanke, H. Strauss, G. Arnold, and J. D. Schipke Analysis of respiratory water---a new method for evaluation of myocardial energy metabolism J Appl Physiol, November 1, 1996; 81(5): 2115 - 2122. [Abstract] [Full Text] [PDF]

				J. D. Rossen, Y. Agmon, R. Gorlin, E.C. Abbott, K. Egashira, and A. Takeshita Endothelial Dysfunction in Microvascular Angina N. Engl. J. Med., December 2, 1993; 329(23): 1739 - 1740. [Full Text]

				K. Egashira, T. Inou, Y. Hirooka, A. Yamada, Y. Urabe, and A. Takeshita Evidence of Impaired Endothelium-Dependent Coronary Vasodilatation in Patients with Angina Pectoris and Normal Coronary Angiograms N. Engl. J. Med., June 10, 1993; 328(23): 1659 - 1664. [Abstract] [Full Text]